Literature DB >> 15243218

Hyperlipidaemia and aortic valve disease.

Anne Bjørhovde Rossebø1, Terje R Pedersen.   

Abstract

PURPOSE OF REVIEW: Degenerative aortic valve stenosis is a common disease in the elderly, and traditional risk factors for atherosclerotic disease including hyperlipidaemia have been associated with the condition in several studies. This review addresses the role of the various risk factors and the potential for intervention. RECENT
FINDINGS: The association of lipid abnormalities such as high lipoprotein(a) levels and the presence of the apolipoprotein E4 allele with aortic stenosis, as well as the presence of several inflammatory markers both in plasma and in surgically excised valves, suggest that the stenotic process is driven by many of the same factors behind atherosclerosis. The aortic valves of animals fed a cholesterol-rich diet exhibit many characteristics in common with the early stages of aortic stenosis. This opens up the potential of retarding the process through intervention strategies.
SUMMARY: Hyperlipidaemia is associated with degenerative aortic valve stenosis, and the disease resembles the inflammatory process of atherosclerosis. Randomized controlled clinical trials will be needed to demonstrate the role of lipid intervention in patients with this condition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15243218     DOI: 10.1097/01.mol.0000137229.00020.fe

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  8 in total

1.  Increased Calcific Aortic Valve Disease in response to a diabetogenic, procalcific diet in the LDLr-/-ApoB100/100 mouse model.

Authors:  Marta Scatena; Melissa F Jackson; Mei Y Speer; Elizabeth M Leaf; Mary C Wallingford; Cecilia M Giachelli
Journal:  Cardiovasc Pathol       Date:  2018-02-15       Impact factor: 2.185

Review 2.  The 'valvulo-metabolic' risk in calcific aortic valve disease.

Authors:  Patrick Mathieu; J P Després; P Pibarot
Journal:  Can J Cardiol       Date:  2007-10       Impact factor: 5.223

Review 3.  Ongoing clinical trials of the pleiotropic effects of statins.

Authors:  Jean Davignon; Lawrence A Leiter
Journal:  Vasc Health Risk Manag       Date:  2005

Review 4.  Is there evidence for statins in the treatment of aortic valve stenosis?

Authors:  Ibrahim Akin; Christoph A Nienaber
Journal:  World J Cardiol       Date:  2017-08-26

5.  Inhibition of MAPK-Erk pathway in vivo attenuates aortic valve disease processes in Emilin1-deficient mouse model.

Authors:  Charu Munjal; Anil G Jegga; Amy M Opoka; Ivan Stoilov; Russell A Norris; Craig J Thomas; J Michael Smith; Robert P Mecham; Giorgio M Bressan; Robert B Hinton
Journal:  Physiol Rep       Date:  2017-03

6.  Augmented osteogenic responses in human aortic valve cells exposed to oxLDL and TLR4 agonist: a mechanistic role of Notch1 and NF-κB interaction.

Authors:  Qingchun Zeng; Rui Song; Lihua Ao; Dingli Xu; Neil Venardos; David A Fullerton; Xianzhong Meng
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

7.  Development of Aortic Valve Disease in Familial Hypercholesterolemic Swine: Implications for Elucidating Disease Etiology.

Authors:  Ana M Porras; Dhanansayan Shanmuganayagam; Jennifer J Meudt; Christian G Krueger; Timothy A Hacker; Peter S Rahko; Jess D Reed; Kristyn S Masters
Journal:  J Am Heart Assoc       Date:  2015-10-27       Impact factor: 5.501

Review 8.  Aortic valve disease in diabetes: Molecular mechanisms and novel therapies.

Authors:  Ileana Manduteanu; Dan Simionescu; Agneta Simionescu; Maya Simionescu
Journal:  J Cell Mol Med       Date:  2021-09-24       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.